Evotec Investor Presentation Deck

Clinical Preclinical Discovery evotec PAGE 27 Ph3 Ph2 IP2X3 - CC Ph1 Jingxin Bayer Bayer ND ND ND ND ND ND ND ND ND ND ND Partnered Pipeline Neuroscience & Pain P2X3 - OAB ₁ Centrexion Bayer ND ND EVT ND ND ND ND ND ND P2X3 - DNP BMS EVT EVT EVT EVT EVT EVT Bayer - B1 Exscientia Aeovian Despite P2x3 set back - The iceberg keeps growing >220 projects including EVOequity and BRIDGEs: ~180 in partnerships, >40 internal R&D Facio Exscientia Argobio LAB282 LAB282 B EVOroyalty Autobahn Facio Cajal Neuro Exscientia EVT CureXsys Unpartnered Pipeline LAB282 LAB150 BI/Xynomic Exscientia Kazia Sanofi/ Apeiron ND ND EVT EVT EVT ND ND ND ND ND ND ND ND ND ND EVT EVT/MF EVT/MF EVT/MF EVT/Indiv EVT EVT ND Oncology EVT EVT Carrick EVT EVT EVT EVT EVT EVT Carrick Carrick Carrick Exscientia Exscientia Autobahn Immunitas Exscientia Breakpoint Autobahn Breakpoint Blacksmith Immunitas Quantro Ananke Autobahn Exscientia OxVax Carrick DarkBlue LAB282 Danube Labs BELAB1407 BELAB2122 Bridges Pipeline LAB282 LAB150 Argobio Metabolic Diseases Bayer ND QRbeta ND EVT ND ND ND ND ND ND ND EVT E.IBETA EVT EVT EVT ND ND ND EVT EVT EVT EVT N=4 Equity Pipeline 1) Also includes Women's Health, Respiratory projects The Equity Pipeline does not contain programs from EVT/partners that are not publically disclosed Eternygen Neph Thera LAB282 Neph Thera EVT EVT EVT EVT LAB282 LAB150 Neph Thera IP2X3 - Endo Bayer Conba ND Topas ND ND ND ND ND Inflammation & Immunology¹) EVT Bayer Fibrocor Topas Exscientia Topas Celmatix ND ND Autobahn Celmatix CureXsys Exscientia Fibrocor LAB150 LAB282 Topas Topas Exscientia LAB150 LAB282 Fibrocor Celmatix Blacksmith Fibrocor Sanofi ND ND Virology ND ND ND ND ND ND LAB282 ND Exscientia LAB282 Anti-bacterial Nosopharm ND Myxob ND ND ND ND Forge Forge Forge Forge Exscientia Global Health SK bioscience ND ND ND ND ND ND ND ND ND

View entire presentation